A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years

Journal of Infectious Diseases

Volumn 207, Issue 12, 2013, Pages 1878-1887

  Domachowske, Joseph B ^a   Pankow Culot, Heidemarie ^b   Bautista, Milagros ^c   Feng, Yang ^d   Claeys, Carine ^d   Peeters, Mathieu ^d   Innis, Bruce L ^e   Jain, Varsha ^e  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b Pediatric Office   (Germany)

^c University of the East Ramon Magsaysay   (Philippines)

^d GSK   (Belgium)

^e GLAXOSMITHKLINE   (United States)

Author keywords

noninferiority; pediatric; quadrivalent; seasonal influenza; superiority; trivalent

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ANOREXIA; ANTIBODY RESPONSE; ARTHRALGIA; ARTICLE; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; ERYTHEMA; FATIGUE; FEBRILE CONVULSION; FEMALE; GASTROINTESTINAL DISEASE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOGENICITY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; INJECTION SITE PAIN; INJECTION SITE REACTION; IRRITABILITY; MALE; MULTICENTER STUDY; MYALGIA; NORMAL HUMAN; PAIN; PHASE 3 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SCHOOL CHILD; SEROCONVERSION; SHIVERING; SIDE EFFECT; SWELLING; VIRUS STRAIN;

NONINFERIORITY; PEDIATRIC; QUADRIVALENT; SEASONAL INFLUENZA; SUPERIORITY; TRIVALENT;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DOUBLE-BLIND METHOD; EUROPE; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HIV SEROPOSITIVITY; HUMANS; INFANT; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PHILIPPINES; SAFETY; UNITED STATES; VACCINATION; VACCINES, INACTIVATED;

EID: 84877998592     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit091     Document Type: Article

References (27)

1. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005; 353:2559-67.
2. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:1-62.
3. Heikkinen T, Silvennoinen H, Peltola V, et al. Burden of influenza in children in the community. J Infect Dis 2004; 190:1369-73.
4. Moore DL, Vaudry W, Scheifele DW, et al. Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004. Pediatrics 2006; 118: e610-9.
5. O'Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004; 113:585-93.
6. Hite LK, Glezen WP, Demmler GJ, Munoz FM. Medically attended pe-diatric influenza during the resurgence of the Victoria lineage of influenza B virus. Int J Infect Dis 2007; 11:40-7.
7. Hu JJ, Kao CL, Lee PI, et al. Clinical features of influenza A and B in children and association with myositis. J Microbiol Immunol Infect 2004; 37:95-8.
8. Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis 2003; 36:299-305.
9. Ampofo WK, Baylor N, Cobey S, et al. Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010. Influenza Other Respi Viruses 2012; 6:142-52, e1-e5.
10. Centers for Disease Control and Prevention. Seasonal influenza activity surveillance reports: 2000-2001 to 2010-2011 seasons. http://www.cdc. gov/flu/weekly/pastreports.htm. Accessed 19 March 2013.
11. Belshe RB, Coelingh K, Ambrose CS, Woo JC, Wu X. Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. Vaccine 2010; 28:2149-56.
12. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother 2012; 8:81-88.
13. Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine 2010; 28(Suppl 4):D45-53.
14. United States Centers for Disease Control and Prevention. Seasonal influenza activity surveillance reports: 2000-2001 to 2010-2011 seasons. http://www.cdc.gov/flu/weekly/pastreports.htm. Accessed 19 March 2013.
15. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season, 2012. http://www.who.int/influenza/vaccines/virus/recommen dations/201202- recommendation.pdf. Accessed 19 March 2013.
16. Fiore AE, Uyeki TM, Broder K, et al. Centers for Disease Control and Prevention. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010; 59:1-62.
17. Hehme N, Künzel W, Petschke F, et al. Ten years of experience with the trivalent split-influenza vaccine, Fluarix™. Clin Drug Invest 2002; 22:751-769.
18. Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-8.
19. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep 2009; 58:1-52.
20. Glezen WP, Couch RB, Taber LH, et al. Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. Am J Epidemiol 1980; 111:13-22.
21. Li WC, Shih SR, Huang YC, et al. Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan. J Clin Virol 2008; 42:45-51.
22. Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med 2007; 4:e247.
23. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-86.
24. Esposito S, Cantarutti L, Molteni CG, et al. Clinical manifestations and socio-economic impact of influenza among healthy children in the community. J Infect 2011; 62:379-87.
25. Centers for Disease Control and Prevention (CDC). Influenza-associated pediatric deaths-United States, September 2010-August 2011. MMWR Morb Mortal Wkly Rep. 2011; 60(36):1233-8.
26. Centers for Disease Control and Prevention. 2010-2011 Influenza Season Summary. http://www.cdc.gov/flu/weekly/weeklyarchives2010-2011/10-11summary.htm. Accessed 19 March 2013.
27. European Centre for Disease Prevention and Control. Weekly influenza surveillance overview. http://ecdc.europa.eu/en/publications/surveillance- reports/influenza/pages/weekly-influenza-surveillance-overview.aspx. Accessed 19 March 2013.